Gene · 6822
Papers1,461
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,461
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DHEA and Its Metabolites Reduce the Cytokines Involved in the Inflammatory Response and Fibrosis in Primary Biliary Cholangitis. | Int J Mol Sci | 2023 | 36982376 | PubTator, text mining | PubMed |
| Differential Effects of ABCG5/G8 Gene Region Variants on Lipid Profile, Blood Pressure Status, and Gallstone Disease History in Taiwan. | Genes (Basel) | 2023 | 36981027 | PubTator, text mining | PubMed |
| Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants. | Biomedicines | 2023 | 36979919 | PubTator, text mining | PubMed |
| Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis. | Medicines (Basel) | 2023 | 36976310 | PubTator, text mining | PubMed |
| Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management. | J Clin Endocrinol Metab | 2023 | 36950738 | PubTator, text mining | PubMed |
| Tp53 haploinsufficiency is involved in hotspot mutations and cytoskeletal remodeling in gefitinib-induced drug-resistant EGFRL858R-lung cancer mice. | Cell Death Discov | 2023 | 36918558 | PubTator, text mining | PubMed |
| Tiered approach to evaluate the CYP3A victim and perpetrator drug-drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling. | CPT Pharmacometrics Syst Pharmacol | 2023 | 36896795 | PubTator, text mining | PubMed |
| Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors. | Front Endocrinol (Lausanne) | 2023 | 36875461 | PubTator, text mining | PubMed |
| Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies. | Gut Microbes | 2023 | 36864554 | PubTator, text mining | PubMed |
| Development of Prognostic Features of Hepatocellular Carcinoma Based on Metabolic Gene Classification and Immune and Oxidative Stress Characteristic Analysis. | Oxid Med Cell Longev | 2023 | 36860731 | PubTator, text mining | PubMed |
| Regulation of Human Endogenous Metabolites by Drug Transporters and Drug Metabolizing Enzymes: An Analysis of Targeted SNP-Metabolite Associations. | Metabolites | 2023 | 36837791 | PubTator, text mining | PubMed |
| Salivary Diagnostics in Pediatrics and the Status of Saliva-Based Biosensors. | Biosensors (Basel) | 2023 | 36831972 | PubTator, text mining | PubMed |
| Dehydrovomifoliol Alleviates Nonalcoholic Fatty Liver Disease via the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular Docking Study. | Evid Based Complement Alternat Med | 2023 | 36777627 | PubTator, text mining | PubMed |
| Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib in vitro and in vivo. | Pharm Biol | 2023 | 36728978 | PubTator, text mining | PubMed |
| HepaRG cells undergo increased levels of post-differentiation patterning in physiologic conditions when maintained as 3D cultures in paper-based scaffolds. | bioRxiv | 2023 | 36711996 | PubTator, text mining | PubMed |
| HepaRG cells undergo increased levels of post-differentiation patterning in physiologic conditions when maintained as 3D cultures in paper-based scaffolds. | Res Sq | 2023 | 36711963 | PubTator, text mining | PubMed |
| PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales. | J Transl Autoimmun | 2023 | 36684809 | PubTator, text mining | PubMed |
| Achieving a Deeper Understanding of Drug Metabolism and Responses Using Single-Cell Technologies. | Drug Metab Dispos | 2023 | 36627162 | PubTator, text mining | PubMed |
| Longitudinal proteomic profiling of the inflammatory response in dengue patients. | PLoS Negl Trop Dis | 2023 | 36595532 | PubTator, text mining | PubMed |
| Multi-Omics Studies in Historically Excluded Populations: The Road to Equity. | Clin Pharmacol Ther | 2023 | 36495075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6822/papers?page=7